• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4632662)   Today's Articles (2372)   Subscriber (49914)
For: Bell R. Efficacy of Ibandronate in Metastatic Bone Disease: Review of Clinical Data. Oncologist 2005;10 Suppl 1:8-13. [PMID: 16264107 DOI: 10.1634/theoncologist.10-90001-8] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]  Open
Number Cited by Other Article(s)
1
Vieira C, Fragoso M, Pereira D, Medeiros R. Pain prevalence and treatment in patients with metastatic bone disease. Oncol Lett 2019;17:3362-3370. [PMID: 30867771 PMCID: PMC6396205 DOI: 10.3892/ol.2019.10013] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2018] [Accepted: 11/29/2018] [Indexed: 11/30/2022]  Open
2
Djenane M, Chafaa S, Chafai N, Kerkour R, Hellal A. Synthesis, spectral properties and corrosion inhibition efficiency of new ethyl hydrogen [(methoxyphenyl) (methylamino) methyl] phosphonate derivatives: Experimental and theoretical investigation. J Mol Struct 2019. [DOI: 10.1016/j.molstruc.2018.07.087] [Citation(s) in RCA: 23] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
3
Vieira CMP, Fragoso M, Ferreira M, Pereira FF, Pereira D, Medeiros R. The history of cancer pain and bone-targeted agents: 10 most commonly asked questions. Cancer Manag Res 2018;11:37-46. [PMID: 30588109 PMCID: PMC6302803 DOI: 10.2147/cmar.s174731] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]  Open
4
Prolonged recovery time from zoledronic Acid induced acute tubular necrosis: a case report and review of the literature. Case Rep Nephrol 2014;2013:651246. [PMID: 24527249 PMCID: PMC3914195 DOI: 10.1155/2013/651246] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2013] [Accepted: 07/09/2013] [Indexed: 11/17/2022]  Open
5
Ali N, Moiz B, Silat H, Rehan A, Adil S. Improved outcome of myeloma related bone pain with oral analgesics and bisphosphonate therapy: A single-center experience from Pakistan. PROGRESS IN PALLIATIVE CARE 2013. [DOI: 10.1179/1743291x13y.0000000070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
6
Pivot X, Lortholary A, Abadie-Lacourtoisie S, Mefti-Lacheraf F, Pujade-Lauraine E, Lefeuvre C, Letessier S, Morvan P, Dür C, Frimat L. Renal safety of ibandronate 6 mg infused over 15 min versus 60 min in breast cancer patients with bone metastases: a randomized open-label equivalence trial. Breast 2011;20:510-4. [PMID: 21727006 DOI: 10.1016/j.breast.2011.05.006] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2011] [Revised: 05/15/2011] [Accepted: 05/19/2011] [Indexed: 11/25/2022]  Open
7
Evidence-Based Approaches to Pain in Advanced Cancer. Cancer J 2010;16:500-6. [DOI: 10.1097/ppo.0b013e3181f45853] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
8
Meattini I, Bruni A, Scotti V, Livi L, De Luca Cardillo C, Galardi A, Cipressi S, Biti G. Oral ibandronate in metastatic bone breast cancer: the Florence University experience and a review of the literature. J Chemother 2010;22:58-62. [PMID: 20227995 DOI: 10.1179/joc.2010.22.1.58] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
9
Bartsch R, Steger GG. Role of denosumab in breast cancer. Expert Opin Biol Ther 2009;9:1225-33. [DOI: 10.1517/14712590903146877] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
10
Prevention and management of bone metastases in lung cancer: a review. J Thorac Oncol 2009;4:251-9. [PMID: 19179905 DOI: 10.1097/jto.0b013e31819518fc] [Citation(s) in RCA: 89] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
11
Pecherstorfer M. Managing neoplastic bone disease with ibandronic acid: a preclinical and clinical data update. Expert Opin Pharmacother 2008;9:3111-9. [DOI: 10.1517/14656560802482945] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
12
Aapro M, Abrahamsson PA, Body JJ, Coleman RE, Colomer R, Costa L, Crinò L, Dirix L, Gnant M, Gralow J, Hadji P, Hortobagyi GN, Jonat W, Lipton A, Monnier A, Paterson AHG, Rizzoli R, Saad F, Thürlimann B. Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel. Ann Oncol 2008;19:420-32. [PMID: 17906299 DOI: 10.1093/annonc/mdm442] [Citation(s) in RCA: 383] [Impact Index Per Article: 23.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]  Open
13
Oyajobi BO. Multiple myeloma/hypercalcemia. Arthritis Res Ther 2007;9 Suppl 1:S4. [PMID: 17634143 PMCID: PMC1924519 DOI: 10.1186/ar2168] [Citation(s) in RCA: 54] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]  Open
14
Russell RGG. Bisphosphonates: mode of action and pharmacology. Pediatrics 2007;119 Suppl 2:S150-62. [PMID: 17332236 DOI: 10.1542/peds.2006-2023h] [Citation(s) in RCA: 305] [Impact Index Per Article: 17.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]  Open
15
Lipton A. Treatment of Bone Metastases and Bone Pain with Bisphosphonates. ACTA ACUST UNITED AC 2007;4:92-100. [DOI: 10.3816/sct.2007.n.003] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
16
Hasan U, Rasool H. Fragile bones in a young male. South Med J 2006;99:1143-4. [PMID: 17100041 DOI: 10.1097/01.smj.0000240165.98672.d5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
17
Guay DRP. Ibandronate, an experimental intravenous bisphosphonate for osteoporosis, bone metastases, and hypercalcemia of malignancy. Pharmacotherapy 2006;26:655-73. [PMID: 16637795 DOI: 10.1592/phco.26.5.655] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
18
Russell RGG. Bisphosphonates: From Bench to Bedside. Ann N Y Acad Sci 2006;1068:367-401. [PMID: 16831938 DOI: 10.1196/annals.1346.041] [Citation(s) in RCA: 284] [Impact Index Per Article: 15.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
19
Body JJ. Bisphosphonates in metastatic bone disease: renal safety matters. Oncologist 2006;10 Suppl 1:1-2. [PMID: 16264105 DOI: 10.1634/theoncologist.10-90001-1] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]  Open
20
Body JJ, Pfister T, Bauss F. Preclinical Perspectives on Bisphosphonate Renal Safety. Oncologist 2005;10 Suppl 1:3-7. [PMID: 16264106 DOI: 10.1634/theoncologist.10-90001-3] [Citation(s) in RCA: 45] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA